PATENT CLAIM ANALYSIS

Application Number: 16122050
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-02
Patent Classification: ["435", "122000"]

Abstract:
Methods that may be used for the manufacture of the chemical compound (S)-norcoclaurine, (S)-norlaudanosoline, and (S)-norcoclaurine or (S)-norlaudanosoline synthesis intermediates are provided. (S)-Norcoclaurine, (S)-norlaudanosoline, and (S)-norcoclaurine or (S)-norlaudanosoline synthesis intermediates are useful as precursor products in the manufacture of certain medicinal agents.

Claim (Index 26):
A recombinant expression vector comprising in the 5\u2032 to 3\u2032 direction of transcription as operably linked components:\n (i) a nucleic acid sequence capable of controlling expression in a host cell; and \n (ii) a nucleic acid sequence encoding monoamine oxidase (MAO) or a nucleic acid sequence encoding norcoclaurine synthase (NCS).

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 2.18182
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15319568', '15031618', '15507711', '12664142', '11875814']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6514537127920061
- 35 USC 102 Novelty (BERT): 0.6746265949025102
- Combined Prediction Score: 0.6537710010030565
- Mean Citation Score: 506.53779200000014
- Max Citation Score: 884.3435699999999
- Similarity Product: 650.7031333806483

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test